克罗恩病中的口服卡介苗疫苗
Oral BCG vaccine in Crohn's disease.
作者信息
Burnham W R, Lennard-Jones J E, Hecketsweiler P, Colin R, Geffroy Y
出版信息
Gut. 1979 Mar;20(3):229-33. doi: 10.1136/gut.20.3.229.
Abstract
In a randomised double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn's disease. Overall assessment scores deteriorated in nine of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P greater than 0.1). No significant benefit from oral BCG treatment has been demonstrated.
摘要
在一项为期一年的随机双盲试验中，对口服卡介苗与一种对照制剂治疗慢性克罗恩病的效果进行了比较。服用卡介苗的22名患者中有9名总体评估得分恶化，而对照组26名患者中有11名出现这种情况（P = 0.25）；这种恶化严重到足以被视为3名服用卡介苗的患者和7名服用对照制剂的患者出现临床复发（P>0.1）。口服卡介苗治疗未显示出显著益处。
相似文献
1
Oral BCG vaccine in Crohn's disease.克罗恩病中的口服卡介苗疫苗
Gut. 1979 Mar;20(3):229-33. doi: 10.1136/gut.20.3.229.
2
BCG treatment of Crohn's disease.
Am J Gastroenterol. 1979 Feb;71(2):196-201.
3
A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease.对溃疡性结肠炎和克罗恩病治疗中对照研究的批判性综述。
Clin Gastroenterol. 1980 May;9(2):351-69.
4
BCG vaccination and Crohn's disease.卡介苗接种与克罗恩病
Dig Dis Sci. 1980 Dec;25(12):972. doi: 10.1007/BF01308050.
5
Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.转移因子治疗克罗恩病的双盲试验。
Gut. 1979 May;20(5):408-13. doi: 10.1136/gut.20.5.408.
6
Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
Am J Gastroenterol. 1987 Jun;82(6):536-9.
7
A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.一项关于环孢素治疗活动性慢性克罗恩病的安慰剂对照、双盲、随机试验。
N Engl J Med. 1989 Sep 28;321(13):845-50. doi: 10.1056/NEJM198909283211301.
8
Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.柳氮磺胺吡啶对活动期克罗恩病患者的疗效：一项对照双盲研究。
Gut. 1981 May;22(5):404-9. doi: 10.1136/gut.22.5.404.
9
[Treatment of Crohn's disease with BCG. Clinical, radiological, and developmental study].[用卡介苗治疗克罗恩病。临床、放射学及发育学研究]
Arch Fr Mal App Dig. 1971 Jun-Jul;60(6):293-8.
10
[Trial treatment of 5 cases of acute Crohn's ileitis with BCG].
Sem Hop. 1973 Feb 14;49(8):565-71.
引用本文的文献
1
Exploring the relationship between environmental enteric dysfunction and oral vaccine responses.探讨环境肠道功能障碍与口服疫苗反应之间的关系。
Future Microbiol. 2018 Jul;13(9):1055-1070. doi: 10.2217/fmb-2018-0016. Epub 2018 Jun 21.
2
Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.克罗恩病是一种免疫缺陷病吗？一种关于克罗恩病发病机制中可能早期事件的假说。
Dig Dis Sci. 2000 Jun;45(6):1121-9. doi: 10.1023/a:1005541700805.
3
Assessment of drug therapy in inflammatory bowel disease.炎症性肠病的药物治疗评估
Br J Clin Pharmacol. 1982 Aug;14(2):159-70. doi: 10.1111/j.1365-2125.1982.tb01957.x.
4
The certifying surgeons.认证外科医生。
J R Coll Gen Pract. 1981 Jan;31(222):33-7.
5
Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?特发性炎症性肠病：免疫机制在发病机制中起作用吗？
Gastroenterol Jpn. 1982 Oct;17(5):476-88. doi: 10.1007/BF02774726.
6
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.要素饮食作为急性克罗恩病的主要治疗方法：一项对照试验。
Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1859-62. doi: 10.1136/bmj.288.6434.1859.
7
Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.炎症性肠病中的免疫抑制药物。其疗效机制及治疗地位综述。
Drugs. 1989 Aug;38(2):267-88. doi: 10.2165/00003495-198938020-00007.
本文引用的文献
1
Treatment of Crohn's disease with azathioprine: a controlled evaluation.
Gastroenterology. 1974 May;66(5):916-22.
2
Immunopotentiation with BCG. I. Immune response to different strains and preparations.卡介苗的免疫增强作用。I. 对不同菌株和制剂的免疫反应。
J Natl Cancer Inst. 1973 Nov;51(5):1655-67. doi: 10.1093/jnci/51.5.1655.
3
Controlled trial of azathioprine in Crohn's disease.
Lancet. 1971 Dec 11;2(7737):1273-6. doi: 10.1016/s0140-6736(71)90598-8.
4
Controlled trial of azathioprine in Crohn's disease.
Lancet. 1971 Oct 30;2(7731):944-7. doi: 10.1016/s0140-6736(71)90268-6.
5
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.克罗恩病活动指数的制定。全国克罗恩病合作研究。
Gastroenterology. 1976 Mar;70(3):439-44.
6
A controlled trial of azathioprine in Crohn's disease.硫唑嘌呤治疗克罗恩病的对照试验。
Am J Dig Dis. 1975 Aug;20(8):721-6. doi: 10.1007/BF01070829.
7
Cell-mediated immunity and transfer factor in Crohn's disease.克罗恩病中的细胞介导免疫与转移因子
Br Med J. 1976 Jul 10;2(6027):87-8. doi: 10.1136/bmj.2.6027.87-a.
8
Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.硫唑嘌呤作为克罗恩病维持治疗的双盲撤药试验。
Lancet. 1978 Nov 4;2(8097):955-7. doi: 10.1016/s0140-6736(78)92524-2.
9
Levamisole in the treatment of Crohn's disease.左旋咪唑治疗克罗恩病
Lancet. 1977 Aug 20;2(8034):382-5. doi: 10.1016/s0140-6736(77)90307-5.
Zotero 插件